Biological Valves: The Growing Preference for Tissue-Based Heart Valve Replacement

0
2

When a heart valve can no longer function properly, replacement surgery becomes essential — and the choice between mechanical and biological valves is one of the most consequential decisions a patient faces. Biological valves, made from animal tissue (typically bovine pericardium or porcine valves), offer a compelling alternative to mechanical options because they typically do not require lifelong anticoagulation therapy. This advantage is driving strong and sustained demand in the global heart valve market.

The biological valve market encompasses surgical tissue valves, transcatheter heart valves (TAVR/TAVI), and related delivery systems and accessories. Growth is driven by the aging population, rising prevalence of valvular heart disease, and a clear shift in clinical preference toward tissue valves, particularly among older patients who face higher bleeding risks with anticoagulants. The rapid expansion of transcatheter aortic valve replacement has been a major catalyst, enabling treatment of patients who are not candidates for open surgery.

Technological innovation is improving durability and outcomes. Newer-generation tissue valves feature advanced anti-calcification treatments, improved hemodynamics, and better deliverability for transcatheter procedures. However, challenges remain, including limited valve durability in younger patients, high device costs, and complex regulatory pathways.

Despite these hurdles, the biological valve market is expected to grow robustly as aging demographics and minimally invasive techniques continue to reshape cardiac care.

People Also Ask

Q: What is a biological heart valve?
A: A biological valve is made from animal tissue, such as bovine pericardium or porcine valves, used to replace a damaged heart valve without requiring lifelong blood thinners.

Q: How long do biological heart valves last?
A: Biological valves typically last 10–20 years, depending on patient age, valve type, and other factors, with younger patients often experiencing faster degeneration.

Tags: #BiologicalValve #HeartValveReplacement #TAVR #TissueValves #CardiacSurgery #StructuralHeart

Căutare
Categorii
Citeste mai mult
Alte
Europe Li-ion Battery Recycling Market 2026: USD 42.9 Billion by 2032
Europe Li-ion Battery Recycling market size was valued at USD 15.4 billion in 2024. The market is...
By sayantan_roy 2026-07-17 10:37:09 0 469
Health
North America Medical Cooling System Market Expansion Strategies and Industry Outlook 2034
The North America Medical Cooling System Market is driven by increasing adoption of MRI, CT,...
By Shubham112 2026-08-20 07:19:57 0 343
Food
Why Is the Texturized Vegetable Protein Market Expected to Hit USD 3.1 Billion by 2036?
NEWARK, Del., Jun 8, 2026 — The global Texturized Vegetable Protein (TVP) Market is...
By ajaymore 2026-06-08 15:31:28 0 584
Alte
IndiGo Cadet Pilot Program 2026: Complete Guide for Aspiring Pilots
Many students want an airline-linked route to the cockpit, and the IndiGo cadet route is one they...
By pilotspathway 2026-11-06 08:20:27 0 107
Alte
Building Service Company in Norfolk: A Complete Guide to Quality Building and Renovation Services
Planning a building project requires careful preparation, reliable workmanship, and a clear...
By DMakBuildingAndRenovationLTD 2026-10-20 10:53:48 0 507